- Iridin
-
- $0.00 / 5mg
-
2023-02-24
- CAS:491-74-7
- Min. Order: 5mg
- Purity: ≥98%(HPLC)
- Supply Ability: 10 g
- C10465
-
- $3.00 / 1KG
-
2020-01-19
- CAS:491-74-7
- Min. Order: 1KG
- Purity: 98%
- Supply Ability: 1kg,5kg,50kg
|
| Product Name: | C10465 | | Synonyms: | C10465;7-(β-D-Glucopyranosyloxy)-5-hydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy-4H-1-benzopyran-4-one;Irigenin-7-O-β-D-glucopyranoside;Irigenin 7-beta-D-glucopyranoside;Irigenin 7-glucoside;Irigenin-7-O-beta-D-glucopyranoside;Lridin;4H-1-Benzopyran-4-one, 7-(β-D-glucopyranosyloxy)-5-hydroxy-3-(3-hydroxy-4,5-dimethoxyphenyl)-6-methoxy- | | CAS: | 491-74-7 | | MF: | C24H26O13 | | MW: | 522.46 | | EINECS: | | | Product Categories: | | | Mol File: | 491-74-7.mol |  |
| | C10465 Chemical Properties |
| Melting point | 208℃ | | Boiling point | 833.5±65.0 °C(Predicted) | | density | 1.558±0.06 g/cm3 (20 ºC 760 Torr) | | storage temp. | 2-8°C | | pka | 5.96±0.20(Predicted) |
| | C10465 Usage And Synthesis |
| Uses | Iridin is isolated from the iris species which exhibits antioxidant and antidiabetic activity and an α-amylase inhibitor. Lactate dehydrogenase inhibitor. | | Uses | dual Src/Abl tyrosine kinase inhibitor with potent antiproliferative activity | | Definition | ChEBI: A glycosyloxyisoflavone that is irigenin substituted by a beta-D-glucopyranosyl residue at position 7 via a glycosidic linkage. |
| | C10465 Preparation Products And Raw materials |
|